Materiały źródłowe

• #1 Skin Cancer Facts & Statistics

  https://www.skincancer.org/skin-cancer-information/skin-cancer-facts/

  More than 5.4 million cases of nonmelanoma skin cancer were treated in over 3.3 million people in the U.S. in 2012, still considered the best estimate to date. […] The diagnosis and treatment of nonmelanoma skin cancers in the U.S. increased by 77 percent between 1994 and 2014. […] About 90 percent of nonmelanoma skin cancers are associated with exposure to ultraviolet (UV) radiation from the sun. […] Basal cell carcinoma (BCC) is the most common form of skin cancer. An estimated 3.6 million cases of BCC are diagnosed in the U.S. each year. […] Squamous cell carcinoma (SCC) is the second most common form of skin cancer. Approximately 1.8 million cases of SCC are diagnosed in the U.S. each year. […] More than 5,400 people worldwide die of nonmelanoma skin cancer every month. […] Organ transplant patients are approximately 100 times more likely than the general public to develop squamous cell carcinoma. […] One study found that regular daily use of an SPF 15 or higher sunscreen reduces the risk of developing squamous cell carcinoma by about 40 percent when used as directed. […] About 3,000 new cases of Merkel cell carcinoma occur in the U.S. each year. About 40 percent of cases recur.

• #2 Non-Melanoma Cancer | Diagnosis and Treatment

  https://www.genesiscareus.com/en/condition/cancer/non-melanoma-cancer

  Skin cancer is the most prevalent cancer type in the US. Each year, it is estimated there will be 5.4 million non-melanoma skin cancers (NMSCs) diagnosed in the US, with some people being diagnosed with more than one type of NMSC. […] Despite the high occurrence of NMSC, almost all can be successfully treated. Unlike many other cancers, theres a low risk of NMSC spreading to other parts of the body. This means early diagnosis and treatment can result in a positive outcome for most people. […] NMSCs are a group of skin cancers that develop in the upper layers of your skin. They can occur anywhere on the skin, though theyre most commonly found on parts of the body that have experienced long-term sun exposure like the head, face, neck, arms, legs, and back of the hands. […] Although there are several types of NMSC, there are two main types: basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). BCC makes up around 80% of all non-melanoma skin cancer cases whereas SCC is less common.

• #3 Skin Cancer Facts & Statistics

  https://www.skincancer.org/skin-cancer-information/skin-cancer-facts/

  More than 5.4 million cases of nonmelanoma skin cancer were treated in over 3.3 million people in the U.S. in 2012, still considered the best estimate to date. […] The diagnosis and treatment of nonmelanoma skin cancers in the U.S. increased by 77 percent between 1994 and 2014. […] About 90 percent of nonmelanoma skin cancers are associated with exposure to ultraviolet (UV) radiation from the sun. […] Basal cell carcinoma (BCC) is the most common form of skin cancer. An estimated 3.6 million cases of BCC are diagnosed in the U.S. each year. […] Squamous cell carcinoma (SCC) is the second most common form of skin cancer. Approximately 1.8 million cases of SCC are diagnosed in the U.S. each year. […] More than 5,400 people worldwide die of nonmelanoma skin cancer every month. […] Organ transplant patients are approximately 100 times more likely than the general public to develop squamous cell carcinoma. […] One study found that regular daily use of an SPF 15 or higher sunscreen reduces the risk of developing squamous cell carcinoma by about 40 percent when used as directed. […] About 3,000 new cases of Merkel cell carcinoma occur in the U.S. each year. About 40 percent of cases recur.

• #4 Basal and Squamous Cell Carcinoma | Non-melanoma skin cancer | Cancer Council

  https://www.cancer.org.au/cancer-information/types-of-cancer/non-melanoma-skin-cancer

  Non-melanoma skin cancers, now called keratinocyte cancers, are the most common cancers in Australia, however most are not life-threatening. […] There are two main types: basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). […] BCC accounts for about 70% of non-melanoma skin cancers. […] SCC accounts for about 30% of non-melanoma skin cancers. […] A third group of lesions called keratinocyte dysplasias includes solar keratosis, Bowenoid keratosis and squamous cell carcinoma in-situ (Bowen’s disease). […] After being diagnosed with non-melanoma skin cancer, you may feel shocked, upset, anxious or confused. These are normal responses. […] You may find it helpful to talk about your treatment options with your doctors, family and friends. […] The type of treatment depends on the type and size of the cancer and where it is located.

• #5 Non-Melanoma Cancer | Diagnosis and Treatment

  https://www.genesiscareus.com/en/condition/cancer/non-melanoma-cancer

  Skin cancer is the most prevalent cancer type in the US. Each year, it is estimated there will be 5.4 million non-melanoma skin cancers (NMSCs) diagnosed in the US, with some people being diagnosed with more than one type of NMSC. […] Despite the high occurrence of NMSC, almost all can be successfully treated. Unlike many other cancers, theres a low risk of NMSC spreading to other parts of the body. This means early diagnosis and treatment can result in a positive outcome for most people. […] NMSCs are a group of skin cancers that develop in the upper layers of your skin. They can occur anywhere on the skin, though theyre most commonly found on parts of the body that have experienced long-term sun exposure like the head, face, neck, arms, legs, and back of the hands. […] Although there are several types of NMSC, there are two main types: basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). BCC makes up around 80% of all non-melanoma skin cancer cases whereas SCC is less common.

• #6 Updates on the Management of Non-Melanoma Skin Cancer (NMSC)

  https://www.mdpi.com/2227-9032/5/4/82

  Non-melanoma skin cancers (NMSCs) are the most common malignancy worldwide, of which 99% are basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) of skin. […] NMSCs are generally considered a curable diseases, yet they currently pose an increasing global healthcare problem due to rising incidence. […] This article aims to summarize the most recent changes and advances made in NMSC management with a focus on prevention, screening, diagnosis, and staging. […] The incidence of NMSC has been increasing worldwide. […] Prevention strategies are divided into primary and secondary strategies. […] Public education is one of the key aspects of primary prevention, which is aimed to increase group-oriented awareness. […] Secondary prevention strategies include screening of high-risk populations, skin self-examination and physician surveillance, which aim to reduce morbidity and mortality by detecting cancer in its early stages.

• #7 Disease Management: Nonmelanoma Skin Cancer

  https://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/dermatology/nonmelanoma-skin-cancer/

  Nonmelanoma skin cancer (NMSC), is the most common malignancy in humans. […] The average treatment cost of NMSC in the United States from 2007 to 2011 was estimated to be $4.8 billion annually. […] Given the overwhelming incidence and cost of NMSC each year, prevention has become a public health priority. […] Although the number of NMSC is staggering, both BCC and SCC have a better than 95% cure rate if detected and treated early. […] The typical lesion is a small, pearly (waxy) nodule with a central depression and rolled border containing dilated blood vessels. […] Clinical diagnosis of BCC is confirmed by biopsy of the suspected lesion for histopathologic interpretation. […] BCC can be effectively treated by a variety of therapeutic modalities. […] Electrodesiccation and curettage (EDC) is a commonly employed, relatively simple and cost effective method for treatment of BCC.

• #8

  https://www.accc-cancer.org/home/learn/cancer-types/skin-cancer/advanced-non-melanoma-skin-cancers/care-coordination-for-patients-with-advanced-non-melanoma-skin-cancers

  Timely diagnosis and treatment for patients with advanced non-melanoma skin cancer is key to improving outcomes and quality of life for this patient population. […] Effective care coordination between oncologists, dermatologists, and all members of the multidisciplinary care team is vital to achieving prompt diagnosis and treatment. Early referrals are an essential component of high-quality care for advanced non-melanoma skin cancers. […] Early diagnosis and timely referral to oncology are crucial for patients with advanced non-melanoma skin cancer to improve their clinical outcomes, treatment opportunities, and quality of life. Learn about the key role dermatologists play in the referral process and how to foster strong relationships between oncologists and dermatologists.

• #9 Treating Basal & Squamous Cell Skin Cancer | Squamous Cell Treatment | American Cancer Society

  https://www.cancer.org/cancer/types/basal-and-squamous-cell-skin-cancer/treating.html

  If youve been diagnosed with basal or squamous cell skin cancer, your treatment team will discuss your options with you. Its important to weigh the benefits of each treatment option against the possible risks and side effects. […] Most basal and squamous cell cancers (as well as pre-cancers) are treated by dermatologists doctors who specialize in treating skin diseases. […] You might have many other specialists on your treatment team as well, including physician assistants (PAs), nurse practitioners (NPs), nurses, pharmacists, nutrition specialists, social workers, and other health professionals. […] Its important to discuss all of your treatment options, including their goals and possible side effects, with your doctors to help make the decision that best fits your needs. […] People with cancer need support and information, no matter what stage of illness they may be in. Knowing all of your options and finding the resources you need will help you make informed decisions about your care.

• #10 Skin cancer (non-melanoma) | NHS inform

  https://www.nhsinform.scot/illnesses-and-conditions/cancer/cancer-types-in-adults/skin-cancer-non-melanoma/

  Skin cancer is one of the most common cancers in the world. Non-melanoma skin cancer refers to a group of cancers that slowly develop in the upper layers of the skin. […] Speak to your GP if you have any skin abnormality that hasn’t healed after 4 weeks. Although it is unlikely to be skin cancer, it is best to be sure. […] Surgery is the main treatment for non-melanoma skin cancer. This involves removing the cancerous tumour and some of the surrounding skin. […] Treatment for non-melanoma skin cancer is generally successful as, unlike most other types of cancer, there is a considerably lower risk that the cancer will spread to other parts of the body. […] People with cancer should be cared for by a team of specialists that often includes a dermatologist, a plastic surgeon, an oncologist (a radiotherapy and chemotherapy specialist), a pathologist and a specialist nurse.

• #11

  https://www.accc-cancer.org/home/learn/cancer-types/skin-cancer/advanced-non-melanoma-skin-cancers/advanced-nmsc-practices

  To help community cancer centers better diagnose and treat cutaneous non-melanoma skin cancers, ACCC has launched a new project designed to engage all members of multidisciplinary cancer care teams as well as non-oncology specialists on effective practices for supporting, treating, and managing patients with advanced non-melanoma skin cancer. […] Communication is essential in establishing referral networks and professional partnerships to facilitate the seamless coordination of care for patients with non-melanoma skin cancers. […] One of the most important things that health care providers can do for patients with non-melanoma skin cancer is coordinate treatment. Multidisciplinary teams in non-melanoma skin cancer care can help determine the best care plan for each patient and improve the quality of care. […] In recognition of May as skin cancer awareness month, a disease that affects one in five Americans by 70 years of age, ACCC has developed new resources to support advanced skin cancer care.

• #12 Skin cancer (nonmelanoma) | UK Healthcare

  https://ukhealthcare.uky.edu/markey-cancer-center/cancer-types/skin-cancer

  Using state-of-the-art technology and leading-edge medical and surgical interventions, Markeys skin cancer team provides advanced and timely diagnosis and individualized, ongoing care for patients. […] Each patient is cared for by a team of specialists who meet regularly to discuss individual patient cases and skin cancer treatment plans. […] This multidisciplinary team will work with you and your doctor to coordinate a care plan designed to offer the best outcomes. […] When detected early, basal and squamous cell carcinoma have extremely high survival rates, according to the American Cancer Society. […] Most deaths are in older people or in people with suppressed immune systems. […] Clinical trials are research studies aimed at evaluating medical, surgical or behavioral interventions to determine if a new treatment is safe and effective. […] As a patient at Markey, you have a team of people looking at your individual case, applying the most recent cancer knowledge to give you the best chance of survival.

• #13 What to Expect of Non Melanoma | Stanford Health Care

  https://stanfordhealthcare.org/medical-conditions/cancer/non-melanoma/patient-care-resources/what-to-expect.html

  Care for Non-Melanoma Skin Cancer The most common forms of skin cancer are basal cell carcinoma and squamous cell carcinoma. When caught early, they are not only easily treated but also curable with surgery. Stanford has expert dermatologic surgeons experienced in state-of the-art treatment techniques. That ensures the best possible outcome for you. […] What to Expect of Non-Melanoma Care This overview explains our diagnosis and treatment planning, to help you understand what to expect as you go through the first steps of your care. […] Diagnosing Non-Melanoma For everyone who comes to us, we start your care by establishing or confirming a diagnosis. Because non-melanoma is a diverse group of diseases, an accurate diagnosis is critical for your treatment plan. It helps us recommend the most effective treatment options for you, in the right sequence. At Stanford, we tailor the diagnostic phase of non-melanoma care to each individual patient.

• #14 Updates on the Management of Non-Melanoma Skin Cancer (NMSC)

  https://www.mdpi.com/2227-9032/5/4/82

  The gold standard for diagnosing NMSC includes a thorough physical examination followed by conventional biopsy of the lesion for histopathologic examination. […] The current treatment of NMSC is driven by a risk assessment of the lesions. […] According to NCCN 2017 guidelines, NMSC are classified as low- and high-risk lesions. […] NMSCs are considered curable diseases and the treatment mostly comprises of lesion removal. […] Surgical removal of NMSC offers the best overall outcome. […] Although surgical excision remains the most commonly performed procedure in the treatment of NMSC, adequate surgical margins have not yet been defined. […] NCCN currently recommends standard excision as a primary treatment choice for low-risk BCCs that can be excised with 4 mm clinical margins as well as low-risk SCCs that can be excised with 4–6 mm clinical margins.

• #15 Treatment for non-melanoma skin cancer – NHS

  https://www.nhs.uk/conditions/non-melanoma-skin-cancer/treatment/

  Non-melanoma skin cancer can usually be effectively treated. […] Surgery is the main treatment for non-melanoma skin cancer. […] The specialist care team looking after you will: explain the treatments, benefits and side effects […] work with you to create a treatment plan that’s best for you […] discuss the chances of the skin cancer coming back and how it will be treated if it does. […] You’ll have regular check-ups during and after any treatments. […] Surgery is the main treatment for non-melanoma skin cancer, especially if it’s found early. […] Several types of surgery can be used to treat non-melanoma skin cancer, including: cutting out the cancer and some surrounding healthy skin (excisional biopsy) […] freezing the affected skin, which forms a scab that drops off a few weeks later (cryosurgery).

• #16 Treatment for Non-melanoma Skin Cancer | Nebraska Hematology Oncology – Cancer Care Treatment Blood Disorders Clinical Trials Lincoln Nebraska (NE)

  https://www.yourcancercare.com/types-of-cancer/skin-cancer/treatment-for-non-melanoma-skin-cancer

  Non-melanoma skin cancer refers to all types of skin cancer other than melanoma. The two most common types of non-melanoma skin cancer are basal cell carcinoma and squamous cell carcinoma. […] Treatment for non-melanoma skin cancer most often involves surgery, but there are non-surgical approaches that may be considered in certain circumstances. […] The following is a general overview of treatment for non-melanoma skin cancer. Treatment may consist of surgery, radiation therapy, or topical therapy. […] Circumstances unique to each patients situation influence which treatment or treatments are utilized. The information on this website is intended to help educate patients about their treatment options and to facilitate a mutual or shared decision-making process with their physician. […] Mohs micrographic surgery: This procedure is complicated and requires expertise, but is often recommended for the treatment of high-risk basal cell carcinoma or squamous cell carcinoma.

• #17 Non-melanoma Skin Cancer | Baylor Scott & White Health

  https://www.bswhealth.com/conditions/nonmelanoma-skin-cancer

  Non-melanoma skin cancer refers to all cancers that occur in the skin that are not melanoma. […] The Baylor Scott White Health team is experienced in detecting, identifying and removing your skin cancer lesions, including basal cell carcinomas and squamous cell carcinomas. […] Your treatment plan will be determined by your care team based on age, medical history, type and stage of non-melanoma skin cancer, and personal preferences. […] Non-melanoma skin cancer treatment options may include: […] The Skin Malignancy Research and Treatment Center, located at Baylor Scott White Charles A. Sammons Cancer Center Dallas, and the Skin Cancer Center at Baylor Scott White Medical Center Irving combine the expertise of dermatologists, medical and surgical oncologists on the medical staff to provide a destination for the screening, evaluation, research and treatment of malignant skin conditions. […] In Central Texas, Baylor Scott White offers a variety of medical and surgical skin cancer therapies to treat most skin cancers at the College Station Clinic, Round Rock Specialty Clinic and Waco Clinic.

• #18 Treatment for non-melanoma skin cancer – NHS

  https://www.nhs.uk/conditions/non-melanoma-skin-cancer/treatment/

  Non-melanoma skin cancer can usually be effectively treated. […] Surgery is the main treatment for non-melanoma skin cancer. […] The specialist care team looking after you will: explain the treatments, benefits and side effects […] work with you to create a treatment plan that’s best for you […] discuss the chances of the skin cancer coming back and how it will be treated if it does. […] You’ll have regular check-ups during and after any treatments. […] Surgery is the main treatment for non-melanoma skin cancer, especially if it’s found early. […] Several types of surgery can be used to treat non-melanoma skin cancer, including: cutting out the cancer and some surrounding healthy skin (excisional biopsy) […] freezing the affected skin, which forms a scab that drops off a few weeks later (cryosurgery).

• #19 Updates on the Management of Non-Melanoma Skin Cancer (NMSC)

  https://www.mdpi.com/2227-9032/5/4/82

  The gold standard for diagnosing NMSC includes a thorough physical examination followed by conventional biopsy of the lesion for histopathologic examination. […] The current treatment of NMSC is driven by a risk assessment of the lesions. […] According to NCCN 2017 guidelines, NMSC are classified as low- and high-risk lesions. […] NMSCs are considered curable diseases and the treatment mostly comprises of lesion removal. […] Surgical removal of NMSC offers the best overall outcome. […] Although surgical excision remains the most commonly performed procedure in the treatment of NMSC, adequate surgical margins have not yet been defined. […] NCCN currently recommends standard excision as a primary treatment choice for low-risk BCCs that can be excised with 4 mm clinical margins as well as low-risk SCCs that can be excised with 4–6 mm clinical margins.

• #20 Skin Cancer – UChicago Medicine

  https://www.uchicagomedicine.org/cancer/types-treatments/skin-cancer

  Non-surgical treatments may be an option in some cases. Radiation, chemotherapy or immunotherapy may be necessary for advanced cases of skin cancer or when patients are unable to have surgery. […] The type of surgical treatment used depends on the type, size, depth and location of the tumor. In most cases, the procedure is done on an outpatient basis. The most common surgical procedures to remove cancerous areas of the skin are: […] Mohs is used for certain types of skin cancer on the head, neck, feet and genitalia. It offers the highest cure rates (up to 99 percent for certain skin cancers) and leads to the best possible cosmetic result. […] During this procedure, the skin cancer is excised along with a standard amount of normal-appearing skin. This may be used for melanoma and small nonmelanoma skin cancers on the torso and extremities. […] This procedure involves scraping the cancerous growth with a curette and cauterizing the area to destroy residual tumor and to control bleeding. This may be effective for a subtype of basal cell carcinoma and very early squamous cell carcinoma.

• #21 Updates on the Management of Non-Melanoma Skin Cancer (NMSC)

  https://www.mdpi.com/2227-9032/5/4/82

  In high-risk BCCs and local high-risk SCCs, MMS, or surgical resection with complete margin assessment is recommended. […] Several topical agents, such as 5-FU and imiquimod, are FDA approved for superficial BCCs and AKs, while diclofenac and ingenol mebutate are FDA approved for AKs only. […] PDT and laser therapy are relatively newer treatment modalities for NMSCs, with a reasonable success rate in low-risk lesions, though, more research is required to study their long-term outcomes, which may allow for the expansion of their utility in the management of skin cancers. […] Finally, the sonic hedgehog pathway inhibition is another emerging area of the treatment NMSCs with vismodegib and sonidegib already being approved for high-risk BCCs.

• #22 Disease Management: Nonmelanoma Skin Cancer

  https://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/dermatology/nonmelanoma-skin-cancer/

  Current guidelines recommend EDC as an appropriate treatment for primary, well defined lesions, measuring 1 to 2 cm on the trunk and extremities of relatively healthy, immunocompetent patients. […] Mohs micrographic surgery (MMS) is a surgical technique utilized for the removal and complete margin assessment of skin cancer. […] The MMS procedure is predicated on histologically inspecting the entire perimeter and undersurface of the excised specimen to ensure a tumor-free margin. […] Patients with a history of BCC have a higher propensity to develop new cutaneous malignancies, including melanoma. […] Long term follow-up and self- or family-examination in patients who have had a BCC are important methods for monitoring for recurrence and detecting new skin cancers. […] The primary goal in the treatment of BCC is using the most appropriate therapy for complete removal of the malignancy with the highest cure rate and least cosmetic disfigurement or functional impairment.

• #23 Non-Melanoma Cancer | Diagnosis and Treatment

  https://www.genesiscareus.com/en/condition/cancer/non-melanoma-cancer

  In many cases, surgery is performed for low-risk NMSC that are not in cosmetically sensitive areas. […] Cryosurgery uses extreme cold substances (usually liquid nitrogen or carbon dioxide) to freeze and destroy small BCCs and SCCs. […] During this procedure, your surgeon removes the cancer by scraping away layers of cancer cells using an instrument with a circular blade, called a curette. […] Excisional surgery involves cutting out the cancerous tissue and a surrounding margin of healthy skin. […] Mohs surgery, also known as Mohs micrographic surgery, is a technique that causes minimal damage to the surrounding healthy tissue and only removes the skin containing the cancer. […] Radiation therapy is often most appropriate for NMSC where surgery is contraindicated, if the cancer is in a cosmetically sensitive area, or as an additional treatment for advanced disease. […] At GenesisCare, we offer a wide range of drug therapies and the latest anti-cancer drugs for skin cancer treatment, including chemotherapy, targeted therapy and immunotherapy. […] Immunotherapy helps your bodys own immune system recognize and fight the cancer.

• #24 Treatment for non-melanoma skin cancer – NHS

  https://www.nhs.uk/conditions/non-melanoma-skin-cancer/treatment/

  Radiotherapy uses high-energy rays of radiation to kill cancer cells. […] Sometimes radiotherapy is used after surgery to help reduce the chance of the cancer coming back. […] Targeted medicines aim to stop the cancer growing. […] Immunotherapy medicines help your immune system find and kill cancer cells. […] Photodynamic therapy uses light-sensitive medicine and a light source to kill cancer cells. […] Chemotherapy uses medicines to kill cancer cells. […] A chemotherapy cream is sometimes used to treat skin cancers that only affect the top layer of skin.

• #25 Non-Melanoma Skin Cancer Treatment | Targeting Cancer AU & NZ

  https://www.targetingcancer.com.au/treatment-by-cancer-type/non-melanoma-skin-cancer/

  Skin cancer is the most common cancer in Australia and New Zealand and at least 2 in 3 Australians will get skin cancer. […] Non-melanoma skin cancer can occur anywhere on the skin. However, it is often found in areas of long-term sun exposure such as the head, face, neck, arms, legs and back of the hands. […] A highly trained radiation oncology team takes care of people having radiation therapy. This includes radiation oncologists, radiation therapists, medical physicists and radiation oncology nurses. […] Treatment can include: surgery, topical treatments applied to the skin cancer, radiation therapy, medicine such as immunotherapy or chemotherapy. […] Radiation therapy can be used as the main treatment, without surgery, or it can be used after surgery to lower the chances of the cancer coming back.

• #26 Non-Melanoma Skin Cancer Treatment | Targeting Cancer AU & NZ

  https://www.targetingcancer.com.au/treatment-by-cancer-type/non-melanoma-skin-cancer/

  For small and low-risk skin cancers, radiation therapy can work as well as surgery. This can be good for areas like the face, where surgery might not be ideal, or for people who can’t have surgery. […] For larger or more advanced skin cancers, especially those near the lymph nodes, surgery is usually the first choice. The treating team may offer radiation therapy after surgery to get rid of any last cancer cells and improve the chances of a cure. […] The side effects of radiation treatment can be split into 2 groups: Early side effects which occur during and shortly after radiation treatment and Late side effects which can occur months to years after radiation treatment. […] To prevent skin issues after radiation therapy, it’s important to follow the advice of your treating team. They’ll provide tips on creams and dressings as well as general skin care.

• #27

  https://bpac.org.nz/bpj/2013/december/skincancer.aspx

  A Cochrane review found that a wide range of topical treatments were generally comparable in the treatment of solar keratoses, however, there was some evidence that fluorouracil cream may be more effective long-term than cryotherapy. […] Superficial BCC, i.e. restricted to the outermost layers of skin, may be treated topically if the lesions location, the patients general health or the presence of co-morbidities mean excision is impractical or associated with an increased risk of complications or poor cosmetic outcome. […] Surgical excision is the first-line treatment for SCC and is indicated for all invasive SCC. […] Cryotherapy or fluorouracil can be used to treat IEC where the diameter, location or number of lesions make surgery unsuitable. […] Fluorouracil (5%) cream is indicated and fully subsidised for the treatment of pre-cancerous and superficial malignant skin lesions.

• #28

  https://bpac.org.nz/bpj/2013/december/skincancer.aspx

  Imiquimod (5%) cream is subsidised under Special Authority criteria for the treatment of confirmed superficial BCC when standard treatment options, including surgical excision, are contraindicated or inappropriate. […] Patients with a history of pre-cancerous or cancerous skin lesions should be advised that the risk of treated lesions becoming recurrent, or new lesions developing, is increased if they are exposed to excessive UVR. […] Patients who have been treated for non-melanoma skin cancer require follow-up every six to 12 months.

• #29 Skin cancer (non-melanoma) | NHS inform

  https://www.nhsinform.scot/illnesses-and-conditions/cancer/cancer-types-in-adults/skin-cancer-non-melanoma/

  Your cancer team will recommend what they think is the best treatment option, but the final decision will be yours. […] Surgical excision is an operation to cut out the cancer along with surrounding healthy tissue to ensure the cancer is completely removed. […] Mohs micrographic surgery (MMS) is used to treat non-melanoma skin cancers when it’s felt there is a high risk of the cancer spreading or returning. […] Photodynamic therapy (PDT) is used to treat basal cell carcinoma, Bowen’s disease and actinic keratoses. […] Imiquimod cream is a treatment for basal cell carcinoma with a diameter of less than 2cm (0.8 inches). […] Radiotherapy involves using low doses of radiation to destroy the cancer. […] Electrochemotherapy is a possible treatment for non-melanoma skin cancer.

• #30 Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma | Journal for ImmunoTherapy of Cancer

  https://jitc.bmj.com/content/10/12/e005082

  Until recently, systemic therapy of advanced disease was largely unsuccessful, with chemotherapy and targeted therapy having limited benefits. […] NMSC has a high mutational burden with a UV gene signature which likely contributes to immunogenicity of these tumors. […] Anti-PD-1 with either cemiplimab or pembrolizumab is now the standard of care for locally advanced and metastatic CSCC. […] Clinical trials of immunotherapy must be prioritized for further improvement in outcomes. […] In addition, interdisciplinary tumor board decision-making is of critical importance to allow patients to gain access to those innovative and efficacious treatment options.

• #31

  https://link.springer.com/article/10.1007/s11912-024-01570-1

  For mBCC, vismodegib is the initial HHI of choice. […] Adverse effects are a limiting factor in the long-term tolerability of HHIs for patients. […] Cemiplimab was approved in February 2021 for treatment of laBCC in patients who already progressed through or were intolerant to HHIs. […] For mMCC, standard therapy includes anti PD-1 therapy (avelumab, pembrolizumab, nivolumab, or retifanlimab). […] Cytotoxic chemotherapy is still used for patients who have progressed through or who cannot tolerate immunotherapy and is also used for palliative debulking and symptomatic management. […] Immunocompromised patients have a higher risk of developing CSCC with studies suggesting poorer outcomes. […] Several clinical trials are exploring safety and efficacy of immunotherapy for SOTR with advanced skin cancer. […] In this review, we examined the latest advances of systemic therapies for advanced and metastatic non-melanoma skin cancers. Understanding the pathophysiology and molecular background of NMSC has become increasingly essential as more and more targeted therapies are being developed and studied.

• #32 Non-Melanoma Skin Cancer: Staging and Treatment | OncoLink

  https://www.oncolink.org/cancers/skin/non-melanoma-skin-cancers/non-melanoma-skin-cancer-staging-and-treatment

  Radiation therapy uses high-energy x-rays to kill cancer cells. Radiation may be used as the only treatment or along with surgery and/or chemotherapy. Radiation is used as the main treatment for skin cancers that are very large, in an area that makes it hard to remove, or if you cannot have surgery because of other health issues. […] Chemotherapy is the use of anti-cancer medicines that go through your whole body (called systemic). These medicines may be given through a vein (IV, intravenously) or by mouth. More often, non-melanoma skin cancers are treated with topical chemotherapy (goes directly on your skin). Topical chemotherapies do not cause as many side effects as systemic chemotherapy because it does not go through your whole body. […] Targeted therapies are medications that target something specific to the cancer cells, stopping them from growing and dividing. Examples of targeted therapies for non-melanoma skin cancer are: Vismodegib (Erivedge), Sonidegib (Odomzo), Cetuximab (Erbitux). […] Immunotherapy is the use of medications that stimulate (rev up) the immune system to attack and kill cancer cells. Some immunotherapy medications used to treat non-melanoma skin cancer are: Cemiplimab (Libtayo) and Pembrolizumab (Keytruda).

• #33

  https://link.springer.com/article/10.1007/s11912-024-01570-1

  For mBCC, vismodegib is the initial HHI of choice. […] Adverse effects are a limiting factor in the long-term tolerability of HHIs for patients. […] Cemiplimab was approved in February 2021 for treatment of laBCC in patients who already progressed through or were intolerant to HHIs. […] For mMCC, standard therapy includes anti PD-1 therapy (avelumab, pembrolizumab, nivolumab, or retifanlimab). […] Cytotoxic chemotherapy is still used for patients who have progressed through or who cannot tolerate immunotherapy and is also used for palliative debulking and symptomatic management. […] Immunocompromised patients have a higher risk of developing CSCC with studies suggesting poorer outcomes. […] Several clinical trials are exploring safety and efficacy of immunotherapy for SOTR with advanced skin cancer. […] In this review, we examined the latest advances of systemic therapies for advanced and metastatic non-melanoma skin cancers. Understanding the pathophysiology and molecular background of NMSC has become increasingly essential as more and more targeted therapies are being developed and studied.

• #34 Treatment for non-melanoma skin cancer – NHS

  https://www.nhs.uk/conditions/non-melanoma-skin-cancer/treatment/

  Radiotherapy uses high-energy rays of radiation to kill cancer cells. […] Sometimes radiotherapy is used after surgery to help reduce the chance of the cancer coming back. […] Targeted medicines aim to stop the cancer growing. […] Immunotherapy medicines help your immune system find and kill cancer cells. […] Photodynamic therapy uses light-sensitive medicine and a light source to kill cancer cells. […] Chemotherapy uses medicines to kill cancer cells. […] A chemotherapy cream is sometimes used to treat skin cancers that only affect the top layer of skin.

• #35 Non-melanoma skin cancer and the care patients need

  https://journals.rcni.com/nursing-standard/feature/nonmelanoma-skin-cancer-and-the-care-patients-need-ns.37.2.56.s23

  Nurses are an important source of support for patients with these lesions because the physical and emotional impact of diagnosis and treatment can be challenging […] Non-melanoma skin cancer is the most common cancer in the UK and incidence is rising.

• #36 Practice Nursing – Skin cancer: getting back to basics

  https://www.practicenursing.com/content/clinical/skin-cancer-getting-back-to-basics/

  Skin cancer is the most common form of cancer in the UK. […] non-melanoma cancers are responsible for significant disease burden and account for 90% of all skin cancers registered in the UK and Ireland (The National Cancer Registration and Analysis Service, 2022). […] health professionals must educate themselves to better screen for skin cancers, provide advice to patients and ensure they are referred appropriately and receive timely care.

• #37

  https://www.nursingcenter.com/journalarticle?Article_ID=1353164&Journal_ID=54016&Issue_ID=1353059

  Melanoma is the deadliest type of skin cancer. It may begin in or near a mole that changes in color, shape, or size. Nonmelanoma skin cancers include basal cell and squamous cell skin cancers. […] The most common type of skin cancer, basal cell cancer, typically appears on skin that’s had a lot of sun exposure, such as the face and neck. Your chances of getting basal cell skin cancer increase with age, but it’s becoming more common in younger people. […] Most basal cell and squamous cell skin cancers can be removed with surgery. Whether you need other treatments depends on the cancer’s location, cell type, and depth, and whether it’s spread to other parts of the body. […] To protect yourself: Avoid any unnecessary exposure to sun, especially between 10 a.m. and 4 p.m. Whenever you go outdoors, protect your skin with long-sleeved clothes and wide-brimmed hats. Choose a sunscreen with an SPF of at least 30 and protection against ultraviolet A (UVA) and ultraviolet B (UVB) rays. Protect your skin even on cloudy days; clouds don’t block out ultraviolet rays. Reapply water-resistant sunscreen after swimming or sweating profusely, or every 2 to 3 hours. Wear wraparound sunglasses with lenses that filter out both UVA and UVB rays. Stay away from tanning booths and sun lamps.

• #38 High-Risk Non-Melanoma Skin Cancer Clinic | Dermatology | OHSU

  https://www.ohsu.edu/dermatology/high-risk-non-melanoma-skin-cancer-clinic

  High-Risk Non-Melanoma Skin Cancer Clinic provides comprehensive and coordinated care for patients at high risk for skin cancer. This includes organ and bone marrow transplant recipients, patients on long-term or drug-induced immunosuppression, and other patients with an increased risk of skin cancer, such as those with a genetic predisposition. […] Our team of a medical dermatologist and surgical dermatologist provide care that focuses on patient education, skin cancer prevention, and timely recognition and treatment of skin cancers. Our team may also collaborate with other providers (primary care, transplant, general dermatology, among others) to achieve the highest quality individualized care. […] Transplant recipients have a much higher risk of skin cancer than the general public due to the need for long term immunosuppressive medications. With immunosuppression, skin cancers can behave more aggressively than in non-transplant patients and, unfortunately, can occasionally be fatal. Seeing a dermatologist is important for early detection and timely management of skin cancer.

• #39

  https://myhealth.alberta.ca/Health/aftercareinformation/pages/conditions.aspx?hwid=abp7900

  Excision of non-melanoma skin cancer is a treatment to remove, or excise, basal cell and squamous cell cancers (carcinomas) from your skin. […] Most cases of these types of cancer can be cured if they are found and removed early. […] Follow-up care is a key part of your treatment and safety. Be sure to make and go to all appointments, and call your doctor or nurse advice line if you are having problems. […] If your doctor told you how to care for your wound, follow your doctor’s instructions. […] Be safe with medicines. Read and follow all instructions on the label. […] Call your doctor or nurse advice line now or seek immediate medical care if you have signs of infection, such as: Increased pain, swelling, warmth, or redness near the area. […] Watch closely for changes in your health, and be sure to contact your doctor or nurse advice line if you see a change in your skin, such as a growth or mole that grows bigger.

• #40 Nonmelanoma Skin Cancers: A New Standard of Care – Today’s Geriatric Medicine

  https://www.todaysgeriatricmedicine.com/archive/MA23p22.shtml

  Nonmelanoma Skin Cancers: A New Standard of Care […] Among the 3.3 million people diagnosed with NMSC every year, many are retired older adults living in areas with an abundance of outdoor activities and sun exposure. This procedure, called Mohs surgery, is frequently recommended, and it has been a treatment for basal and squamous cell carcinomas for nearly a century. In recent decades, Mohs surgery has become recognized as the gold standard for the treatment of NMSC. […] The amount and type of care a patient needs after Mohs surgery depends on the wound that is left from where the cancer was removed. […] A majority of individuals will require some form of reconstructive surgery after the Mohs surgery is completed in order to minimize surgical defects or improve cosmetic and functional outcomes.

• #41 Non-Melanoma Skin Cancer Treatment | Targeting Cancer AU & NZ

  https://www.targetingcancer.com.au/treatment-by-cancer-type/non-melanoma-skin-cancer/

  For small and low-risk skin cancers, radiation therapy can work as well as surgery. This can be good for areas like the face, where surgery might not be ideal, or for people who can’t have surgery. […] For larger or more advanced skin cancers, especially those near the lymph nodes, surgery is usually the first choice. The treating team may offer radiation therapy after surgery to get rid of any last cancer cells and improve the chances of a cure. […] The side effects of radiation treatment can be split into 2 groups: Early side effects which occur during and shortly after radiation treatment and Late side effects which can occur months to years after radiation treatment. […] To prevent skin issues after radiation therapy, it’s important to follow the advice of your treating team. They’ll provide tips on creams and dressings as well as general skin care.

• #42 Non-Melanoma Skin Cancer Treatment | Targeting Cancer AU & NZ

  https://www.targetingcancer.com.au/treatment-by-cancer-type/non-melanoma-skin-cancer/

  For small and low-risk skin cancers, radiation therapy can work as well as surgery. This can be good for areas like the face, where surgery might not be ideal, or for people who can’t have surgery. […] For larger or more advanced skin cancers, especially those near the lymph nodes, surgery is usually the first choice. The treating team may offer radiation therapy after surgery to get rid of any last cancer cells and improve the chances of a cure. […] The side effects of radiation treatment can be split into 2 groups: Early side effects which occur during and shortly after radiation treatment and Late side effects which can occur months to years after radiation treatment. […] To prevent skin issues after radiation therapy, it’s important to follow the advice of your treating team. They’ll provide tips on creams and dressings as well as general skin care.

• #43 Skin cancer | Macmillan Cancer Support

  https://www.macmillan.org.uk/cancer-information-and-support/skin-cancer

  After you have had treatment for skin cancer it is even more important to protect yourself from the sun. Find out how you can protect your skin in our information about sun safety and cancer treatment. […] If treatment has changed the way you look, you may feel differently about yourself and your body image. Body image is the picture in your mind of how your body looks and works. […] It is important to remember there is no right or wrong way to feel about a skin cancer diagnosis. Everyones reactions are different, and you might have a mixture of emotions.

• #44 Skin cancer | Macmillan Cancer Support

  https://www.macmillan.org.uk/cancer-information-and-support/skin-cancer

  After you have had treatment for skin cancer it is even more important to protect yourself from the sun. Find out how you can protect your skin in our information about sun safety and cancer treatment. […] If treatment has changed the way you look, you may feel differently about yourself and your body image. Body image is the picture in your mind of how your body looks and works. […] It is important to remember there is no right or wrong way to feel about a skin cancer diagnosis. Everyones reactions are different, and you might have a mixture of emotions.

• #45 Skin Cancer Facts & Statistics

  https://www.skincancer.org/skin-cancer-information/skin-cancer-facts/

  More than 5.4 million cases of nonmelanoma skin cancer were treated in over 3.3 million people in the U.S. in 2012, still considered the best estimate to date. […] The diagnosis and treatment of nonmelanoma skin cancers in the U.S. increased by 77 percent between 1994 and 2014. […] About 90 percent of nonmelanoma skin cancers are associated with exposure to ultraviolet (UV) radiation from the sun. […] Basal cell carcinoma (BCC) is the most common form of skin cancer. An estimated 3.6 million cases of BCC are diagnosed in the U.S. each year. […] Squamous cell carcinoma (SCC) is the second most common form of skin cancer. Approximately 1.8 million cases of SCC are diagnosed in the U.S. each year. […] More than 5,400 people worldwide die of nonmelanoma skin cancer every month. […] Organ transplant patients are approximately 100 times more likely than the general public to develop squamous cell carcinoma. […] One study found that regular daily use of an SPF 15 or higher sunscreen reduces the risk of developing squamous cell carcinoma by about 40 percent when used as directed. […] About 3,000 new cases of Merkel cell carcinoma occur in the U.S. each year. About 40 percent of cases recur.

• #46 High-Risk Non-Melanoma Skin Cancer Clinic | Dermatology | OHSU

  https://www.ohsu.edu/dermatology/high-risk-non-melanoma-skin-cancer-clinic

  High-Risk Non-Melanoma Skin Cancer Clinic provides comprehensive and coordinated care for patients at high risk for skin cancer. This includes organ and bone marrow transplant recipients, patients on long-term or drug-induced immunosuppression, and other patients with an increased risk of skin cancer, such as those with a genetic predisposition. […] Our team of a medical dermatologist and surgical dermatologist provide care that focuses on patient education, skin cancer prevention, and timely recognition and treatment of skin cancers. Our team may also collaborate with other providers (primary care, transplant, general dermatology, among others) to achieve the highest quality individualized care. […] Transplant recipients have a much higher risk of skin cancer than the general public due to the need for long term immunosuppressive medications. With immunosuppression, skin cancers can behave more aggressively than in non-transplant patients and, unfortunately, can occasionally be fatal. Seeing a dermatologist is important for early detection and timely management of skin cancer.

• #47 High-Risk Non-Melanoma Skin Cancer Clinic | Dermatology | OHSU

  https://www.ohsu.edu/dermatology/high-risk-non-melanoma-skin-cancer-clinic

  High-Risk Non-Melanoma Skin Cancer Clinic provides comprehensive and coordinated care for patients at high risk for skin cancer. This includes organ and bone marrow transplant recipients, patients on long-term or drug-induced immunosuppression, and other patients with an increased risk of skin cancer, such as those with a genetic predisposition. […] Our team of a medical dermatologist and surgical dermatologist provide care that focuses on patient education, skin cancer prevention, and timely recognition and treatment of skin cancers. Our team may also collaborate with other providers (primary care, transplant, general dermatology, among others) to achieve the highest quality individualized care. […] Transplant recipients have a much higher risk of skin cancer than the general public due to the need for long term immunosuppressive medications. With immunosuppression, skin cancers can behave more aggressively than in non-transplant patients and, unfortunately, can occasionally be fatal. Seeing a dermatologist is important for early detection and timely management of skin cancer.

• #48 High-Risk Non-Melanoma Skin Cancer Clinic | Dermatology | OHSU

  https://www.ohsu.edu/dermatology/high-risk-non-melanoma-skin-cancer-clinic

  Ideally, patients should be seen prior to, or soon after, their transplant. This allows us to determine your risk of skin cancer post-transplant and develop an appropriate skin cancer prevention plan. […] Minimize risk of skin cancer through education and preventative care. […] Provide excellent and coordinated treatment when skin cancers develop.

• #49 Non-Melanoma Cancer | Diagnosis and Treatment

  https://www.genesiscareus.com/en/condition/cancer/non-melanoma-cancer

  Lack of sun protection is one of the highest risks of developing NMSC. […] The most common risk factor of developing NMSC is ultraviolet radiation (UVR) through tanning and inadequate sun protection. […] Youre more likely to develop skin cancer if you: Are older, Have a family history or personal history of skin cancer, Have a rare type of birthmark known as giant congenital melanocytic naevus, Spend lots of time in the sun, Have fair skin which burns easily, Have blonder or red hair, or blue or green eyes, Have reduced immunity or HIV, Have moles the more moles you have, the higher the risk, Have another medical condition such as Chrons disease, ulcerative colitis or sarcoidosis, Have received an organ transplant. […] Typically, NMSC are associated with a mole or growth that changes in size, shape and color, a new growth on the skin, or a sore that does not heal. Your physician may want to run diagnostics if there is any concern of malignancy.

• #50 Update in the treatment of non-melanoma skin cancers: the use of PD-1 inhibitors in basal cell carcinoma and cutaneous squamous-cell carcinoma | Journal for ImmunoTherapy of Cancer

  https://jitc.bmj.com/content/10/12/e005082

  The efficacy of anti-PD-1/PD-ligand (L)1 antibodies in melanoma and other solid tumors is well established. […] Pembrolizumab was initially approved in the USA for recurrent or metastatic CSCC not curable by surgery or radiation, with this indication later expanded to include locally advanced CSCC. […] Cemiplimab is a fully human immunoglobulin G4 anti-PD-1 antibody that is approved for the treatment of metastatic CSCC or locally advanced CSCC not amenable to curative surgery or curative radiation in both Europe and the USA. […] Advanced BCC is rare but very difficult to treat. […] Several case reports of patients with advanced BCC treated with PD-1 inhibitors have been reported, with patients achieving partial or complete responses. […] Immunosuppression is a known risk factor for NMSC and immunosuppressed patients (eg, solid-organ transplant recipients, patients with chronic lymphocytic leukemia, patients with HIV) represent a substantial proportion of patients with NMSC and tend to have more aggressive disease.

• #51

  https://link.springer.com/article/10.1007/s11912-024-01570-1

  For mBCC, vismodegib is the initial HHI of choice. […] Adverse effects are a limiting factor in the long-term tolerability of HHIs for patients. […] Cemiplimab was approved in February 2021 for treatment of laBCC in patients who already progressed through or were intolerant to HHIs. […] For mMCC, standard therapy includes anti PD-1 therapy (avelumab, pembrolizumab, nivolumab, or retifanlimab). […] Cytotoxic chemotherapy is still used for patients who have progressed through or who cannot tolerate immunotherapy and is also used for palliative debulking and symptomatic management. […] Immunocompromised patients have a higher risk of developing CSCC with studies suggesting poorer outcomes. […] Several clinical trials are exploring safety and efficacy of immunotherapy for SOTR with advanced skin cancer. […] In this review, we examined the latest advances of systemic therapies for advanced and metastatic non-melanoma skin cancers. Understanding the pathophysiology and molecular background of NMSC has become increasingly essential as more and more targeted therapies are being developed and studied.

• #52 Skin cancer

  https://www.cancervic.org.au/cancer-information/types-of-cancer/skin_cancers_non_melanoma/skin-cancer-overview.html

  Having one BCC increases the risk of getting another. […] People with many irregular moles (dysplastic naevi) may have a greater risk of developing melanoma. […] You can check the UV levels in your local area on the SunSmart app. […] Learn how to reduce your risk. […] Download our Understanding Skin Cancer booklet to learn more.

• #53 Non-Melanoma Cancer | Diagnosis and Treatment

  https://www.genesiscareus.com/en/condition/cancer/non-melanoma-cancer

  Lack of sun protection is one of the highest risks of developing NMSC. […] The most common risk factor of developing NMSC is ultraviolet radiation (UVR) through tanning and inadequate sun protection. […] Youre more likely to develop skin cancer if you: Are older, Have a family history or personal history of skin cancer, Have a rare type of birthmark known as giant congenital melanocytic naevus, Spend lots of time in the sun, Have fair skin which burns easily, Have blonder or red hair, or blue or green eyes, Have reduced immunity or HIV, Have moles the more moles you have, the higher the risk, Have another medical condition such as Chrons disease, ulcerative colitis or sarcoidosis, Have received an organ transplant. […] Typically, NMSC are associated with a mole or growth that changes in size, shape and color, a new growth on the skin, or a sore that does not heal. Your physician may want to run diagnostics if there is any concern of malignancy.

• #54 What to Expect of Non Melanoma | Stanford Health Care

  https://stanfordhealthcare.org/medical-conditions/cancer/non-melanoma/patient-care-resources/what-to-expect.html

  During Treatment There are two primary approaches to non-melanoma treatment. As we develop treatment recommendations for you, we consider whether the cancer is confined to the skin or has spread to other parts of your body. […] Local therapy targets the tumor in the skin and a small amount of surrounding tissue called a margin. Surgery, certain topical or intralesional agents, and radiation therapy are local treatments. Most non-melanomas are treated only with local surgery. […] Drug therapy treats the entire body with cancer-fighting medications to destroy cancer cells that have spread from the skin to other parts of the body. […] Follow-up care After you complete your non-melanoma treatment, your care team works with you to develop an ongoing care plan. Regular follow-up care, also known as surveillance, is important to: Monitor your overall health, Manage any remaining side effects, Check for possible signs of the cancer coming back (recurring).

• #55

  https://bpac.org.nz/bpj/2013/december/skincancer.aspx

  Imiquimod (5%) cream is subsidised under Special Authority criteria for the treatment of confirmed superficial BCC when standard treatment options, including surgical excision, are contraindicated or inappropriate. […] Patients with a history of pre-cancerous or cancerous skin lesions should be advised that the risk of treated lesions becoming recurrent, or new lesions developing, is increased if they are exposed to excessive UVR. […] Patients who have been treated for non-melanoma skin cancer require follow-up every six to 12 months.

• #56 Disease Management: Nonmelanoma Skin Cancer

  https://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/dermatology/nonmelanoma-skin-cancer/

  Current guidelines recommend EDC as an appropriate treatment for primary, well defined lesions, measuring 1 to 2 cm on the trunk and extremities of relatively healthy, immunocompetent patients. […] Mohs micrographic surgery (MMS) is a surgical technique utilized for the removal and complete margin assessment of skin cancer. […] The MMS procedure is predicated on histologically inspecting the entire perimeter and undersurface of the excised specimen to ensure a tumor-free margin. […] Patients with a history of BCC have a higher propensity to develop new cutaneous malignancies, including melanoma. […] Long term follow-up and self- or family-examination in patients who have had a BCC are important methods for monitoring for recurrence and detecting new skin cancers. […] The primary goal in the treatment of BCC is using the most appropriate therapy for complete removal of the malignancy with the highest cure rate and least cosmetic disfigurement or functional impairment.

• #57

  https://myhealth.alberta.ca/Health/aftercareinformation/pages/conditions.aspx?hwid=abp7900

  Excision of non-melanoma skin cancer is a treatment to remove, or excise, basal cell and squamous cell cancers (carcinomas) from your skin. […] Most cases of these types of cancer can be cured if they are found and removed early. […] Follow-up care is a key part of your treatment and safety. Be sure to make and go to all appointments, and call your doctor or nurse advice line if you are having problems. […] If your doctor told you how to care for your wound, follow your doctor’s instructions. […] Be safe with medicines. Read and follow all instructions on the label. […] Call your doctor or nurse advice line now or seek immediate medical care if you have signs of infection, such as: Increased pain, swelling, warmth, or redness near the area. […] Watch closely for changes in your health, and be sure to contact your doctor or nurse advice line if you see a change in your skin, such as a growth or mole that grows bigger.

• #58

  https://www.nursingcenter.com/journalarticle?Article_ID=1353164&Journal_ID=54016&Issue_ID=1353059

  Melanoma is the deadliest type of skin cancer. It may begin in or near a mole that changes in color, shape, or size. Nonmelanoma skin cancers include basal cell and squamous cell skin cancers. […] The most common type of skin cancer, basal cell cancer, typically appears on skin that’s had a lot of sun exposure, such as the face and neck. Your chances of getting basal cell skin cancer increase with age, but it’s becoming more common in younger people. […] Most basal cell and squamous cell skin cancers can be removed with surgery. Whether you need other treatments depends on the cancer’s location, cell type, and depth, and whether it’s spread to other parts of the body. […] To protect yourself: Avoid any unnecessary exposure to sun, especially between 10 a.m. and 4 p.m. Whenever you go outdoors, protect your skin with long-sleeved clothes and wide-brimmed hats. Choose a sunscreen with an SPF of at least 30 and protection against ultraviolet A (UVA) and ultraviolet B (UVB) rays. Protect your skin even on cloudy days; clouds don’t block out ultraviolet rays. Reapply water-resistant sunscreen after swimming or sweating profusely, or every 2 to 3 hours. Wear wraparound sunglasses with lenses that filter out both UVA and UVB rays. Stay away from tanning booths and sun lamps.

• #59 Skin care after skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/skin-cancer/living-with/skin-care-after-skin-cancer

  When you’ve had skin cancer, you are more at risk of developing another skin cancer. So its important to keep an eye on your skin and protect it when out in the sun. […] Remember, most non melanoma skin cancers are treated successfully. Its rare for early stage skin cancers to come back. […] If you’ve had skin cancer, you should avoid spending too long in the sun. Use a sunscreen product with at least a sun protector factor (SPF) of 15 and apply generously. Your skin cancer specialist might suggest a high factor sunscreen such as 50 on any exposed skin. […] In the UK, the level of UVA protection is shown in 1 of 2 ways: […] Non melanoma skin cancer includes basal cell skin cancer, squamous cell skin cancer and other rare types. […] Non melanoma skin cancer includes basal cell carcinoma, squamous cell carcinoma and other rare types. They tend to develop most often on skin that has been exposed to the sun.

• #60 Skin care after skin cancer | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/skin-cancer/living-with/skin-care-after-skin-cancer

  When you’ve had skin cancer, you are more at risk of developing another skin cancer. So its important to keep an eye on your skin and protect it when out in the sun. […] Remember, most non melanoma skin cancers are treated successfully. Its rare for early stage skin cancers to come back. […] If you’ve had skin cancer, you should avoid spending too long in the sun. Use a sunscreen product with at least a sun protector factor (SPF) of 15 and apply generously. Your skin cancer specialist might suggest a high factor sunscreen such as 50 on any exposed skin. […] In the UK, the level of UVA protection is shown in 1 of 2 ways: […] Non melanoma skin cancer includes basal cell skin cancer, squamous cell skin cancer and other rare types. […] Non melanoma skin cancer includes basal cell carcinoma, squamous cell carcinoma and other rare types. They tend to develop most often on skin that has been exposed to the sun.

• #61 Skin cancer | Macmillan Cancer Support

  https://www.macmillan.org.uk/cancer-information-and-support/skin-cancer

  After you have had treatment for skin cancer it is even more important to protect yourself from the sun. Find out how you can protect your skin in our information about sun safety and cancer treatment. […] If treatment has changed the way you look, you may feel differently about yourself and your body image. Body image is the picture in your mind of how your body looks and works. […] It is important to remember there is no right or wrong way to feel about a skin cancer diagnosis. Everyones reactions are different, and you might have a mixture of emotions.

• #62

  https://www.estro.org/Courses/2024/Multidisciplinary-Management-of-Non-melanoma-Skin

  As the incidence of non-melanoma skin cancer (NMSC) increases worldwide, this interactive course highlights the need to improve interdisciplinary collaboration. This course covers everything in the field of NMSC from epidemiology, dermatopathology, surgical and non-surgical treatments, skin radiobiology and skin care during treatment in radical, palliative and supportive care. […] This course aims to bring various specialists and trainees in the field of dermato-oncology in order to breach gaps between specializations, increase multidisciplinary understanding and highlight the need for improved interdisciplinary collaboration. […] Develop a deep understanding of best practices in NMSC and provide patients with the best possible treatment, skin care advice and follow-up care. […] Role of allied health care professionals in NMSC management. […] Follow-up and management of side effects during and after skin cancer treatment. […] Understand challenges of palliative and supportive care in NMSC patients.

• #63 Treating Basal & Squamous Cell Skin Cancer | Squamous Cell Treatment | American Cancer Society

  https://www.cancer.org/cancer/types/basal-and-squamous-cell-skin-cancer/treating.html

  Different types of programs and support services may be helpful, and they can be an important part of your care. These might include nursing or social work services, financial aid, nutritional advice, rehab, or spiritual help. […] Remember that even if you choose not to treat the cancer, you can still get supportive care to help with pain or other symptoms. […] Nursing care and special equipment can make staying at home a workable option for many families.

• #64 Treating Basal & Squamous Cell Skin Cancer | Squamous Cell Treatment | American Cancer Society

  https://www.cancer.org/cancer/types/basal-and-squamous-cell-skin-cancer/treating.html

  Different types of programs and support services may be helpful, and they can be an important part of your care. These might include nursing or social work services, financial aid, nutritional advice, rehab, or spiritual help. […] Remember that even if you choose not to treat the cancer, you can still get supportive care to help with pain or other symptoms. […] Nursing care and special equipment can make staying at home a workable option for many families.

• #65 Treating Basal & Squamous Cell Skin Cancer | Squamous Cell Treatment | American Cancer Society

  https://www.cancer.org/cancer/types/basal-and-squamous-cell-skin-cancer/treating.html

  Different types of programs and support services may be helpful, and they can be an important part of your care. These might include nursing or social work services, financial aid, nutritional advice, rehab, or spiritual help. […] Remember that even if you choose not to treat the cancer, you can still get supportive care to help with pain or other symptoms. […] Nursing care and special equipment can make staying at home a workable option for many families.

• #66 Non-melanoma skin cancer: signs, risk factors and nursing care

  https://journals.rcni.com/cancer-nursing-practice/feature/nonmelanoma-skin-cancer-signs-risk-factors-and-nursing-care-cnp.21.2.12.s8

  Nurses are an important source of support for people with this form of cancer, whose treatment can be harrowing […] Non-melanoma skin cancer (NMSC) is the most common cancer in the UK and incidence is rising. Almost 400,000 diagnoses a year are expected by 2025, says the major UK report State of the Nation: Non-melanoma Skin Cancer published in 2021. Yet many members of the public do not recognise it as a form of cancer and would struggle to identify its signs and symptoms.

• #67

  https://www.accc-cancer.org/home/learn/cancer-types/skin-cancer/advanced-non-melanoma-skin-cancers/advanced-nmsc-practices

  To help community cancer centers better diagnose and treat cutaneous non-melanoma skin cancers, ACCC has launched a new project designed to engage all members of multidisciplinary cancer care teams as well as non-oncology specialists on effective practices for supporting, treating, and managing patients with advanced non-melanoma skin cancer. […] Communication is essential in establishing referral networks and professional partnerships to facilitate the seamless coordination of care for patients with non-melanoma skin cancers. […] One of the most important things that health care providers can do for patients with non-melanoma skin cancer is coordinate treatment. Multidisciplinary teams in non-melanoma skin cancer care can help determine the best care plan for each patient and improve the quality of care. […] In recognition of May as skin cancer awareness month, a disease that affects one in five Americans by 70 years of age, ACCC has developed new resources to support advanced skin cancer care.

Zobacz więcej